(NASDAQ:VVUS) hit a new 52-week low and has $0.58 target or 7.00% below today's $0.62 share price. The investment management company reported $0.36 EPS for the quarter, beating the Zacks' consensus estimate of $0.35 by $0.01. If the $0.58 price target is reached, the company will be worth $4.60M less. Vaughan Nelson Investment Management L.P. lifted its stake in shares of Ares Capital by 1.6% in the third quarter. It is down 21.80% since December 6, 2016 and is downtrending. It has underperformed by 23.84% the S&P500. Tudor Corporation Et Al stated it has 0.03% in Ares Capital Corporation (NASDAQ:ARCC). Shareholders of record on Thursday, June 15th will be given a $0.38 dividend. Goldman Sachs Group has 2.42 million shares. The stock has been active on the tape, now trading at $16.10, down from yesterday's close by -0.49%. About 863,500 shares traded. Ares Capital Corp now has $6.92 billion valuation. It has underperformed by 6.98% the S&P500.
Investors sentiment decreased to 1.16 in 2017 Q2. Its down 1.69, from 3.25 in 2017Q1. Novanta Inc was reduced too. 16 funds opened positions while 17 raised stakes. 2,797 are held by Meeder Asset Mngmt Inc. Royal Natl Bank Of Canada has invested 0% in VIVUS, Inc. Moreover, Invest Limited Liability has 0.04% invested in Ares Capital Corporation (NASDAQ:ARCC). "(NASDAQ:ARCC) Holdings Boosted by Yorktown Management & Research Co Inc" was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. Thrivent Fincl For Lutherans reported 0% of its portfolio in OraSure Technologies, Inc.
Analysts await Ares Capital Corporation (NASDAQ:ARCC) to report earnings on February, 28. National Bank & Trust Of Ny Mellon holds 18,827 shares.
Ares Capital Corporation is a specialty finance company. (NASDAQ:VVUS). Sg Americas Secs Lc has invested 0% in VIVUS, Inc.
Several research analysts have recently issued reports on ARES shares. Macquarie Group Limited, Australia-based fund reported 24,100 shares. Moreover, Clinton Gp has 0.03% invested in Ares Management, L.P. (NYSE:ARES) for 14,661 shares. It closed at $73.29 lastly. After $0.40 actual earnings per share reported by Ares Management, L.P. for the previous quarter, Wall Street now forecasts 2.50 % EPS growth. Meanwhile, the price rate of change (ROC) is now -0.679, indicating a Sell. Therefore 71% are positive. The stock stands almost -9.46% off versus the 52-week high and 4.52% away from the 52-week low. Grupo Televisa SAB had 21 analyst reports since September 4, 2015 according to SRatingsIntel. The firm has "Buy" rating given on Thursday, November 2 by Canaccord Genuity. Keefe Bruyette & Woods has "Buy" rating and $2200 target. The firm earned "Outperform" rating on Friday, April 7 by Wood.
VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet medical needs in the United States and the European Union. For ARCC, the company now has $341 Million of cash on the books, which is offset by $ current liabilities.
It is common practice for investors to use the price-to-earnings ratio (P/E ratio or price multiple) to determine if a company's stock price is over or undervalued. It is also developing Qsymia, which has completed Phase II studies for the treatment of obstructive sleep apnea and diabetes, as well as for other obesity-related diseases, including nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, hyperlipidemia, and hypertension. The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 1.90, which implies that analysts are generally bullish in their outlook for ARCC over the next year. Therefore 67% are positive.
Ares Capital Corporation (ARCC) has been given an average price target of $18.03 from analysts, according to data collected by Finviz. The rating was maintained by Citigroup with "Buy" on Friday, August 21. On Wednesday, May 31 the stock rating was maintained by BMO Capital Markets with "Hold". On Sunday, July 23 the stock rating was maintained by Keefe Bruyette & Woods with "Buy". The firm has "Buy" rating given on Wednesday, September 20 by Oppenheimer. The company has a consensus rating of Buy and an average target price of $18.06.
After staying quite for a long time Ares Capital Corporation (NASDAQ:ARCC) shares have recently been behaving interestingly to keep investors awake. The rating was maintained by RBC Capital Markets on Friday, November 3 with "Hold". Its down 0.38, from 1.51 in 2017Q1. It is negative, as 63 investors sold ARCC shares while 88 reduced holdings. There were 34 sold out positions, on the other hand, totaling 4,062,794 shares.
Mirador Capital Partners LP raised its position in shares of Ares Capital Co. Art Advisors Llc accumulated 16,400 shares. Penn Mutual Life stated it has 490,000 shares or 7.05% of all its holdings. It also upped Alcentra Capital Corp (NASDAQ:ABDC) stake by 157,251 shares and now owns 610,164 shares. Raymond James Assoc invested in 0.02% or 609,381 shares. Eam Investors Ltd Co holds 295,349 shares or 0.84% of its portfolio. Credit Suisse upgraded the stock to "Hold" rating in Monday, May 1 report. BMO Capital Markets maintained Ares Capital Corporation (NASDAQ:ARCC) on Tuesday, November 14 with "Hold" rating. Walleye Trading Ltd Llc has 47,261 shares for 0% of their portfolio.